Qatar not considering bid for Marks & Spencer - source
DUBAI/LONDON (Reuters) - Qatar Holding, the investment arm of the Gulf state's sovereign wealth fund, is not considering a bid for British retailer Marks & Spencer(MKS.L), a source close to the fund said on Monday.
Shares in Marks & Spencer (M&S) jumped 8 percent in early Monday trading after The Sunday Times newspaper said the Qatar Investment Authority wanted to assemble a consortium to mount an 8-billion-pound takeover of Britain's biggest clothing retailer.
Qatar Holding is the vehicle through which the wealth fund conducts some of its biggest overseas investments.
M&S declined to comment.
Despite the denial from the source, some analysts think M&S, whose core women's clothes business has been losing market share, could be vulnerable to a private equity bid.
"Trading and profits are under pressure, with nothing to show yet for the big investments made in online systems and warehousing and the changes in the clothing team," said independent retail analyst Nick Bubb.
He also noted that from a funding perspective, the recent improvement in the debt markets and the amount of money currently in private equity makes a bid possible.
"From a strategic perspective, however, the question is what anybody thinks could be done with a declining brand like M&S."
One of M&S's top 20 shareholders also told Reuters a private equity-style bid was possible.
"You could argue that the business could support quite a bit of debt if it wasn't having to pay a dividend," said the investor.
(Reporting by Dinesh Nair and James Davey; additional reporting by Chris Vellacott; Editing by Andrew Torchia and Mark Potter)
- Tweet this
- Share this
- Digg this
- UPDATE 3-U.S. FDA probes cognitive impact of new cholesterol drugs
- Malaysia Airlines loses contact with plane carrying 239 people
- UPDATE 3-Boeing reports wing cracks on 787 Dreamliners in production
- UPDATE 2-White House plays down speedy role for U.S. natural gas in Ukraine
- Exclusive - Pimco's Gross declares El-Erian is 'trying to undermine me'
Drug maker Ranbaxy Laboratories Ltd has recalled more than 64,000 bottles of the generic versions of its cholesterol-lowering drug in the United States due to reports of a dose mix-up, U.S. regulators said. Full Article